-
ARS Pharmaceuticals (NASDAQ:SPRY) Given Outperform Rating at William Blair
Source: Buzz FX / 03 Mar 2025 09:16:16 America/Chicago
ARS Pharmaceuticals (NASDAQ:SPRY) Given Outperform Rating at William Blair Written by MarketBeat March 3, 2025 Share Link copied to clipboard. ARS Pharmaceuticals ( NASDAQ:SPRY - Get Free Report ) 's stock had its "outperform" rating reiter
Read more...